Foundation Medicine FoundationOneRNA

Foundation Medicine has launched a new research use and investigational use version of FoundationOneRNA, a tissue-based RNA sequencing test that detects fusions in 318 genes. The company said it uses an extraction method whereby DNA and RNA can be isolated from a single formalin-fixed paraffin-embedded sample to minimize sample volume requirements and help researchers preserve limited tissue samples in clinical studies. The assay also has expanded capabilities to offer gene expression reporting of over 1,500 genes to support biomarker discovery. Foundation Medicine said it is developing a clinical-use version of the test with an anticipated launch in 2024.